SCHEMBL23970619

SCHEMBL23970619

CC(C)(C)OC(=O)c1c(CCCCCO)ccnc1C1CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.35
TDP1 Q9NUW8 1/20 0.32
HCRTR1 O43613 1/20 0.31
HCRTR2 O43614 1/20 0.31
CYP4F2 P78329 2/20 0.31
CYP4A11 Q02928 2/20 0.31
SSTR4 P31391 1/20 0.31
FAAH O00519 1/20 0.30
CXCR4 P61073 1/20 0.30
GPR119 Q8TDV5 2/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GLA P06280 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23970618 0.86 DUT (0.33) FAAH
SCHEMBL23971324 0.82 TDP1 (0.35) TDP1CYP4F2CYP4A11SSTR4KDM4E
SCHEMBL29187852 0.82 PSMD10 (0.37) GPR119
SCHEMBL30159151 0.82 PSMD10 (0.37) GPR119
SCHEMBL23970620 0.81 ATR (0.40) TDP1CYP4F2CYP4A11SSTR4KDM4E
SCHEMBL23970566 0.81 SSTR4 (0.38) TDP1CYP4F2CYP4A11SSTR4KDM4E
SCHEMBL28950549 0.78 TDP1 (0.33) TDP1CYP4F2CYP4A11SSTR4KDM4E
SCHEMBL30159187 0.72 PPARA (0.39) TDP1CYP4F2CYP4A11
SCHEMBL23971426 0.72 PPARA (0.39) TDP1CYP4F2CYP4A11
SCHEMBL23970622 0.71 SSTR4 (0.41) TDP1CYP4F2CYP4A11SSTR4GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551862-B Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2024-04-12 CN disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
CN-115551862-A Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2022-12-30 CN disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 CNR2 4620/4885TDP1 199/4885HCRTR1 4254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.